HEADER OXIDOREDUCTASE 21-JUN-11 3ZS1 TITLE HUMAN MYELOPEROXIDASE INACTIVATED BY TX5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MYELOPEROXIDASE LIGHT CHAIN; COMPND 3 CHAIN: A, B; COMPND 4 EC: 1.11.2.2; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: MYELOPEROXIDASE HEAVY CHAIN; COMPND 7 CHAIN: C, D; COMPND 8 EC: 1.11.2.2 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: HL-60; SOURCE 6 ATCC: CCL240; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 CELL_LINE: HL-60; SOURCE 12 ATCC: CCL240 KEYWDS OXIDOREDUCTASE, ENZYME INACTIVATION, INFLAMMATION, NEUTROPHIL, KEYWDS 2 REACTIVE OXYGEN SPECIES (ROS), HYPOCHLOROUS ACID EXPDTA X-RAY DIFFRACTION AUTHOR A.K.TIDEN,T.SJOGREN,M.SVENSSON,A.BERNLIND,R.SENTHILMOHAN,F.AUCHERE, AUTHOR 2 H.NORMAN,P.O.MARKGREN,S.GUSTAVSSON,S.SCHMIDT,S.LUNDQUIST,L.V.FORBES, AUTHOR 3 N.J.MAGON,G.N.JAMESON,H.ERIKSSON,A.J.KETTLE REVDAT 7 06-NOV-24 3ZS1 1 REMARK REVDAT 6 20-DEC-23 3ZS1 1 HETSYN REVDAT 5 29-JUL-20 3ZS1 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE ATOM REVDAT 4 28-JUN-17 3ZS1 1 REMARK REVDAT 3 16-SEP-15 3ZS1 1 SOURCE REVDAT 2 15-AUG-12 3ZS1 1 JRNL REVDAT 1 31-AUG-11 3ZS1 0 JRNL AUTH A.K.TIDEN,T.SJOGREN,M.SVENSSON,A.BERNLIND,R.SENTHILMOHAN, JRNL AUTH 2 F.AUCHERE,H.NORMAN,P.O.MARKGREN,S.GUSTAVSSON,S.SCHMIDT, JRNL AUTH 3 S.LUNDQUIST,L.V.FORBES,N.J.MAGON,L.N.PATON,G.N.JAMESON, JRNL AUTH 4 H.ERIKSSON,A.J.KETTLE JRNL TITL 2-THIOXANTHINES ARE MECHANISM-BASED INACTIVATORS OF JRNL TITL 2 MYELOPEROXIDASE THAT BLOCK OXIDATIVE STRESS DURING JRNL TITL 3 INFLAMMATION. JRNL REF J.BIOL.CHEM. V. 286 37578 2011 JRNL REFN ISSN 0021-9258 JRNL PMID 21880720 JRNL DOI 10.1074/JBC.M111.266981 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 110.43 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 38218 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2015 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2839 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.63 REMARK 3 BIN R VALUE (WORKING SET) : 0.2390 REMARK 3 BIN FREE R VALUE SET COUNT : 132 REMARK 3 BIN FREE R VALUE : 0.3080 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9138 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 303 REMARK 3 SOLVENT ATOMS : 259 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.06000 REMARK 3 B22 (A**2) : 0.68000 REMARK 3 B33 (A**2) : -1.81000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.24000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.327 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.228 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.670 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.917 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.866 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 9765 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 13306 ; 1.818 ; 2.010 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1136 ; 4.816 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 466 ;34.631 ;22.918 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1566 ;14.993 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 108 ;15.553 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1438 ; 0.127 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7632 ; 0.009 ; 0.022 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5742 ; 0.535 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 9300 ; 1.053 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 4023 ; 1.604 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 4006 ; 2.702 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY. REMARK 4 REMARK 4 3ZS1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-JUN-11. REMARK 100 THE DEPOSITION ID IS D_1290048766. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-MAY-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : VARIMAX-VHF REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU A200 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40244 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 30.790 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.14000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.67 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.36000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1CXP REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16-17% PEG3350, 100 MM NACL, PH 5.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.89500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23010 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -90.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -96.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A -1 REMARK 465 THR A 0 REMARK 465 ALA A 105 REMARK 465 ARG A 106 REMARK 465 ALA A 107 REMARK 465 SER A 108 REMARK 465 PHE A 109 REMARK 465 VAL A 110 REMARK 465 THR A 111 REMARK 465 GLY A 112 REMARK 465 VAL B -1 REMARK 465 THR B 0 REMARK 465 ALA B 105 REMARK 465 ARG B 106 REMARK 465 ALA B 107 REMARK 465 SER B 108 REMARK 465 PHE B 109 REMARK 465 VAL B 110 REMARK 465 THR B 111 REMARK 465 GLY B 112 REMARK 465 SER C 579 REMARK 465 SER D 579 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CMA HEM A 605 S12 PVW A 606 2.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 2 117.52 -34.18 REMARK 500 SER A 42 -38.88 -153.53 REMARK 500 TRP A 47 -73.03 -64.12 REMARK 500 PHE B 41 -17.09 -144.66 REMARK 500 SER B 42 -47.38 -153.28 REMARK 500 ARG C 136 -50.45 -139.40 REMARK 500 ASP C 142 -175.50 -58.30 REMARK 500 ASN C 215 75.54 -113.18 REMARK 500 HIS C 217 -76.09 -67.02 REMARK 500 SER C 315 159.21 179.13 REMARK 500 ASN C 348 9.35 -65.91 REMARK 500 GLN C 396 54.31 -144.89 REMARK 500 ASN C 457 89.69 -175.08 REMARK 500 PHE D 126 66.56 -152.86 REMARK 500 ARG D 136 -56.84 -132.93 REMARK 500 ASN D 215 69.27 -109.00 REMARK 500 ARG D 314 -71.78 -111.85 REMARK 500 ASN D 457 99.67 -166.15 REMARK 500 LYS D 488 15.57 56.00 REMARK 500 ASN D 555 -2.65 -151.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA C1580 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 96 O REMARK 620 2 ASP A 96 OD1 74.2 REMARK 620 3 THR C 168 O 68.9 141.9 REMARK 620 4 THR C 168 OG1 130.3 147.9 69.0 REMARK 620 5 PHE C 170 O 104.8 84.2 95.9 104.6 REMARK 620 6 ASP C 172 OD1 150.9 78.1 139.7 73.1 80.9 REMARK 620 7 SER C 174 OG 86.4 78.6 107.9 82.5 156.1 79.5 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 605 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS C 336 NE2 REMARK 620 2 HEM A 605 NA 102.0 REMARK 620 3 HEM A 605 NB 104.4 90.5 REMARK 620 4 HEM A 605 NC 80.5 177.4 88.6 REMARK 620 5 HEM A 605 ND 105.3 89.2 149.7 90.3 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA D1580 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 96 O REMARK 620 2 ASP B 96 OD1 73.2 REMARK 620 3 THR D 168 OG1 138.9 145.9 REMARK 620 4 THR D 168 O 76.6 149.2 64.9 REMARK 620 5 PHE D 170 O 100.5 89.2 93.6 90.3 REMARK 620 6 ASP D 172 OD1 154.4 81.2 66.2 128.8 78.5 REMARK 620 7 SER D 174 OG 87.1 76.2 91.9 108.6 160.9 87.0 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 605 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 336 NE2 REMARK 620 2 HEM B 605 NA 97.5 REMARK 620 3 HEM B 605 NB 106.3 88.7 REMARK 620 4 HEM B 605 NC 84.9 177.6 90.4 REMARK 620 5 HEM B 605 ND 104.2 90.8 149.3 88.8 REMARK 620 N 1 2 3 4 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1D2V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF BROMIDE-BOUND HUMAN MYELOPEROXIDASE ISOFORM C REMARK 900 AT PH 5.5 REMARK 900 RELATED ID: 1CXP RELATED DB: PDB REMARK 900 CRYOGENIC CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C REMARK 900 RELATED ID: 1DNU RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSES OF HUMAN MYELOPEROXIDASE- THIOCYANATECOMPLEX REMARK 900 RELATED ID: 1D7W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM CCOMPLEXED WITH REMARK 900 CYANIDE AND BROMIDE AT PH 4.0 REMARK 900 RELATED ID: 1DNW RELATED DB: PDB REMARK 900 HUMAN MYELOPEROXIDASE-CYANIDE-THIOCYANATE COMPLEX REMARK 900 RELATED ID: 1MHL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C CRYSTALLIZED REMARK 900 IN SPACE GROUP P2(1) AT PH 5.5 AND 20 DEG C REMARK 900 RELATED ID: 1D5L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CYANIDE-BOUND HUMAN MYELOPEROXIDASEISOFORM C REMARK 900 AT PH 5.5 REMARK 900 RELATED ID: 1MYP RELATED DB: PDB REMARK 900 MYELOPEROXIDASE REMARK 900 RELATED ID: 3ZS0 RELATED DB: PDB REMARK 900 HUMAN MYELOPEROXIDASE INACTIVATED BY TX2 DBREF 3ZS1 A -1 112 UNP P05164 PERM_HUMAN 70 183 DBREF 3ZS1 B -1 112 UNP P05164 PERM_HUMAN 70 183 DBREF 3ZS1 C 113 579 UNP P05164 PERM_HUMAN 184 650 DBREF 3ZS1 D 113 579 UNP P05164 PERM_HUMAN 184 650 SEQRES 1 A 114 VAL THR CYS PRO GLU GLN ASP LYS TYR ARG THR ILE THR SEQRES 2 A 114 GLY MET CYS ASN ASN ARG ARG SER PRO THR LEU GLY ALA SEQRES 3 A 114 SER ASN ARG ALA PHE VAL ARG TRP LEU PRO ALA GLU TYR SEQRES 4 A 114 GLU ASP GLY PHE SER LEU PRO TYR GLY TRP THR PRO GLY SEQRES 5 A 114 VAL LYS ARG ASN GLY PHE PRO VAL ALA LEU ALA ARG ALA SEQRES 6 A 114 VAL SER ASN GLU ILE VAL ARG PHE PRO THR ASP GLN LEU SEQRES 7 A 114 THR PRO ASP GLN GLU ARG SER LEU MET PHE MET GLN TRP SEQRES 8 A 114 GLY GLN LEU LEU ASP HIS ASP LEU ASP PHE THR PRO GLU SEQRES 9 A 114 PRO ALA ALA ARG ALA SER PHE VAL THR GLY SEQRES 1 B 114 VAL THR CYS PRO GLU GLN ASP LYS TYR ARG THR ILE THR SEQRES 2 B 114 GLY MET CYS ASN ASN ARG ARG SER PRO THR LEU GLY ALA SEQRES 3 B 114 SER ASN ARG ALA PHE VAL ARG TRP LEU PRO ALA GLU TYR SEQRES 4 B 114 GLU ASP GLY PHE SER LEU PRO TYR GLY TRP THR PRO GLY SEQRES 5 B 114 VAL LYS ARG ASN GLY PHE PRO VAL ALA LEU ALA ARG ALA SEQRES 6 B 114 VAL SER ASN GLU ILE VAL ARG PHE PRO THR ASP GLN LEU SEQRES 7 B 114 THR PRO ASP GLN GLU ARG SER LEU MET PHE MET GLN TRP SEQRES 8 B 114 GLY GLN LEU LEU ASP HIS ASP LEU ASP PHE THR PRO GLU SEQRES 9 B 114 PRO ALA ALA ARG ALA SER PHE VAL THR GLY SEQRES 1 C 467 VAL ASN CYS GLU THR SER CYS VAL GLN GLN PRO PRO CYS SEQRES 2 C 467 PHE PRO LEU LYS ILE PRO PRO ASN ASP PRO ARG ILE LYS SEQRES 3 C 467 ASN GLN ALA ASP CYS ILE PRO PHE PHE ARG SER CSO PRO SEQRES 4 C 467 ALA CYS PRO GLY SER ASN ILE THR ILE ARG ASN GLN ILE SEQRES 5 C 467 ASN ALA LEU THR SER PHE VAL ASP ALA SER MET VAL TYR SEQRES 6 C 467 GLY SER GLU GLU PRO LEU ALA ARG ASN LEU ARG ASN MET SEQRES 7 C 467 SER ASN GLN LEU GLY LEU LEU ALA VAL ASN GLN ARG PHE SEQRES 8 C 467 GLN ASP ASN GLY ARG ALA LEU LEU PRO PHE ASP ASN LEU SEQRES 9 C 467 HIS ASP ASP PRO CYS LEU LEU THR ASN ARG SER ALA ARG SEQRES 10 C 467 ILE PRO CYS PHE LEU ALA GLY ASP THR ARG SER SER GLU SEQRES 11 C 467 MET PRO GLU LEU THR SER MET HIS THR LEU LEU LEU ARG SEQRES 12 C 467 GLU HIS ASN ARG LEU ALA THR GLU LEU LYS SER LEU ASN SEQRES 13 C 467 PRO ARG TRP ASP GLY GLU ARG LEU TYR GLN GLU ALA ARG SEQRES 14 C 467 LYS ILE VAL GLY ALA MET VAL GLN ILE ILE THR TYR ARG SEQRES 15 C 467 ASP TYR LEU PRO LEU VAL LEU GLY PRO THR ALA MET ARG SEQRES 16 C 467 LYS TYR LEU PRO THR TYR ARG SER TYR ASN ASP SER VAL SEQRES 17 C 467 ASP PRO ARG ILE ALA ASN VAL PHE THR ASN ALA PHE ARG SEQRES 18 C 467 TYR GLY HIS THR LEU ILE GLN PRO PHE MET PHE ARG LEU SEQRES 19 C 467 ASP ASN ARG TYR GLN PRO MET GLU PRO ASN PRO ARG VAL SEQRES 20 C 467 PRO LEU SER ARG VAL PHE PHE ALA SER TRP ARG VAL VAL SEQRES 21 C 467 LEU GLU GLY GLY ILE ASP PRO ILE LEU ARG GLY LEU MET SEQRES 22 C 467 ALA THR PRO ALA LYS LEU ASN ARG GLN ASN GLN ILE ALA SEQRES 23 C 467 VAL ASP GLU ILE ARG GLU ARG LEU PHE GLU GLN VAL MET SEQRES 24 C 467 ARG ILE GLY LEU ASP LEU PRO ALA LEU ASN MET GLN ARG SEQRES 25 C 467 SER ARG ASP HIS GLY LEU PRO GLY TYR ASN ALA TRP ARG SEQRES 26 C 467 ARG PHE CYS GLY LEU PRO GLN PRO GLU THR VAL GLY GLN SEQRES 27 C 467 LEU GLY THR VAL LEU ARG ASN LEU LYS LEU ALA ARG LYS SEQRES 28 C 467 LEU MET GLU GLN TYR GLY THR PRO ASN ASN ILE ASP ILE SEQRES 29 C 467 TRP MET GLY GLY VAL SER GLU PRO LEU LYS ARG LYS GLY SEQRES 30 C 467 ARG VAL GLY PRO LEU LEU ALA CYS ILE ILE GLY THR GLN SEQRES 31 C 467 PHE ARG LYS LEU ARG ASP GLY ASP ARG PHE TRP TRP GLU SEQRES 32 C 467 ASN GLU GLY VAL PHE SER MET GLN GLN ARG GLN ALA LEU SEQRES 33 C 467 ALA GLN ILE SER LEU PRO ARG ILE ILE CYS ASP ASN THR SEQRES 34 C 467 GLY ILE THR THR VAL SER LYS ASN ASN ILE PHE MET SER SEQRES 35 C 467 ASN SER TYR PRO ARG ASP PHE VAL ASN CYS SER THR LEU SEQRES 36 C 467 PRO ALA LEU ASN LEU ALA SER TRP ARG GLU ALA SER SEQRES 1 D 467 VAL ASN CYS GLU THR SER CYS VAL GLN GLN PRO PRO CYS SEQRES 2 D 467 PHE PRO LEU LYS ILE PRO PRO ASN ASP PRO ARG ILE LYS SEQRES 3 D 467 ASN GLN ALA ASP CYS ILE PRO PHE PHE ARG SER CSO PRO SEQRES 4 D 467 ALA CYS PRO GLY SER ASN ILE THR ILE ARG ASN GLN ILE SEQRES 5 D 467 ASN ALA LEU THR SER PHE VAL ASP ALA SER MET VAL TYR SEQRES 6 D 467 GLY SER GLU GLU PRO LEU ALA ARG ASN LEU ARG ASN MET SEQRES 7 D 467 SER ASN GLN LEU GLY LEU LEU ALA VAL ASN GLN ARG PHE SEQRES 8 D 467 GLN ASP ASN GLY ARG ALA LEU LEU PRO PHE ASP ASN LEU SEQRES 9 D 467 HIS ASP ASP PRO CYS LEU LEU THR ASN ARG SER ALA ARG SEQRES 10 D 467 ILE PRO CYS PHE LEU ALA GLY ASP THR ARG SER SER GLU SEQRES 11 D 467 MET PRO GLU LEU THR SER MET HIS THR LEU LEU LEU ARG SEQRES 12 D 467 GLU HIS ASN ARG LEU ALA THR GLU LEU LYS SER LEU ASN SEQRES 13 D 467 PRO ARG TRP ASP GLY GLU ARG LEU TYR GLN GLU ALA ARG SEQRES 14 D 467 LYS ILE VAL GLY ALA MET VAL GLN ILE ILE THR TYR ARG SEQRES 15 D 467 ASP TYR LEU PRO LEU VAL LEU GLY PRO THR ALA MET ARG SEQRES 16 D 467 LYS TYR LEU PRO THR TYR ARG SER TYR ASN ASP SER VAL SEQRES 17 D 467 ASP PRO ARG ILE ALA ASN VAL PHE THR ASN ALA PHE ARG SEQRES 18 D 467 TYR GLY HIS THR LEU ILE GLN PRO PHE MET PHE ARG LEU SEQRES 19 D 467 ASP ASN ARG TYR GLN PRO MET GLU PRO ASN PRO ARG VAL SEQRES 20 D 467 PRO LEU SER ARG VAL PHE PHE ALA SER TRP ARG VAL VAL SEQRES 21 D 467 LEU GLU GLY GLY ILE ASP PRO ILE LEU ARG GLY LEU MET SEQRES 22 D 467 ALA THR PRO ALA LYS LEU ASN ARG GLN ASN GLN ILE ALA SEQRES 23 D 467 VAL ASP GLU ILE ARG GLU ARG LEU PHE GLU GLN VAL MET SEQRES 24 D 467 ARG ILE GLY LEU ASP LEU PRO ALA LEU ASN MET GLN ARG SEQRES 25 D 467 SER ARG ASP HIS GLY LEU PRO GLY TYR ASN ALA TRP ARG SEQRES 26 D 467 ARG PHE CYS GLY LEU PRO GLN PRO GLU THR VAL GLY GLN SEQRES 27 D 467 LEU GLY THR VAL LEU ARG ASN LEU LYS LEU ALA ARG LYS SEQRES 28 D 467 LEU MET GLU GLN TYR GLY THR PRO ASN ASN ILE ASP ILE SEQRES 29 D 467 TRP MET GLY GLY VAL SER GLU PRO LEU LYS ARG LYS GLY SEQRES 30 D 467 ARG VAL GLY PRO LEU LEU ALA CYS ILE ILE GLY THR GLN SEQRES 31 D 467 PHE ARG LYS LEU ARG ASP GLY ASP ARG PHE TRP TRP GLU SEQRES 32 D 467 ASN GLU GLY VAL PHE SER MET GLN GLN ARG GLN ALA LEU SEQRES 33 D 467 ALA GLN ILE SER LEU PRO ARG ILE ILE CYS ASP ASN THR SEQRES 34 D 467 GLY ILE THR THR VAL SER LYS ASN ASN ILE PHE MET SER SEQRES 35 D 467 ASN SER TYR PRO ARG ASP PHE VAL ASN CYS SER THR LEU SEQRES 36 D 467 PRO ALA LEU ASN LEU ALA SER TRP ARG GLU ALA SER MODRES 3ZS1 ASN C 189 ASN GLYCOSYLATION SITE MODRES 3ZS1 ASN C 225 ASN GLYCOSYLATION SITE MODRES 3ZS1 ASN C 317 ASN GLYCOSYLATION SITE MODRES 3ZS1 ASN D 189 ASN GLYCOSYLATION SITE MODRES 3ZS1 ASN D 225 ASN GLYCOSYLATION SITE MODRES 3ZS1 ASN D 317 ASN GLYCOSYLATION SITE MODRES 3ZS1 CSO C 150 CYS S-HYDROXYCYSTEINE MODRES 3ZS1 CSO D 150 CYS S-HYDROXYCYSTEINE HET CSO C 150 7 HET CSO D 150 7 HET NAG E 1 14 HET NAG E 2 14 HET BMA E 3 11 HET FUC E 4 10 HET NAG F 1 14 HET NAG F 2 14 HET BMA F 3 11 HET HEM A 605 43 HET PVW A 606 15 HET HEM B 605 43 HET PVW B 606 15 HET SO4 C1579 5 HET CA C1580 1 HET CL C1581 1 HET SO4 C1582 5 HET ACT C1583 4 HET ACT C1584 4 HET ACT C1585 4 HET NAG C1620 14 HET NAG C1630 14 HET SO4 D1579 5 HET CA D1580 1 HET CL D1581 1 HET ACT D1582 4 HET ACT D1583 4 HET ACT D1584 4 HET NAG D2620 14 HET NAG D2630 14 HETNAM CSO S-HYDROXYCYSTEINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM PVW 3-(2-METHOXYETHYL)-2-THIOXO-1,2,3,7-TETRAHYDRO-6H- HETNAM 2 PVW PURIN-6-ONE HETNAM SO4 SULFATE ION HETNAM CA CALCIUM ION HETNAM CL CHLORIDE ION HETNAM ACT ACETATE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN HEM HEME FORMUL 3 CSO 2(C3 H7 N O3 S) FORMUL 5 NAG 8(C8 H15 N O6) FORMUL 5 BMA 2(C6 H12 O6) FORMUL 5 FUC C6 H12 O5 FORMUL 7 HEM 2(C34 H32 FE N4 O4) FORMUL 8 PVW 2(C8 H10 N4 O2 S) FORMUL 11 SO4 3(O4 S 2-) FORMUL 12 CA 2(CA 2+) FORMUL 13 CL 2(CL 1-) FORMUL 15 ACT 6(C2 H3 O2 1-) FORMUL 28 HOH *259(H2 O) HELIX 1 1 LEU A 60 VAL A 69 1 10 HELIX 2 2 PRO A 72 LEU A 76 5 5 HELIX 3 3 LEU A 84 ASP A 98 1 15 HELIX 4 4 LEU B 60 VAL B 69 1 10 HELIX 5 5 PRO B 72 LEU B 76 5 5 HELIX 6 6 LEU B 84 ASP B 98 1 15 HELIX 7 7 ALA C 173 GLY C 178 1 6 HELIX 8 8 GLU C 180 LEU C 187 1 8 HELIX 9 9 ASP C 219 THR C 224 5 6 HELIX 10 10 MET C 243 ASN C 268 1 26 HELIX 11 11 ASP C 272 ASP C 295 1 24 HELIX 12 12 TYR C 296 GLY C 302 1 7 HELIX 13 13 GLY C 302 LEU C 310 1 9 HELIX 14 14 ALA C 325 PHE C 332 1 8 HELIX 15 15 ARG C 333 ILE C 339 5 7 HELIX 16 16 SER C 362 VAL C 364 5 3 HELIX 17 17 SER C 368 GLU C 374 1 7 HELIX 18 18 ILE C 377 THR C 387 1 11 HELIX 19 19 VAL C 399 GLU C 404 1 6 HELIX 20 20 ASP C 416 HIS C 428 1 13 HELIX 21 21 GLY C 432 CYS C 440 1 9 HELIX 22 22 THR C 447 ARG C 456 1 10 HELIX 23 23 ASN C 457 GLY C 469 1 13 HELIX 24 24 ASP C 475 GLU C 483 1 9 HELIX 25 25 GLY C 492 GLY C 509 1 18 HELIX 26 26 SER C 521 ALA C 529 1 9 HELIX 27 27 SER C 532 THR C 541 1 10 HELIX 28 28 SER C 565 LEU C 567 5 3 HELIX 29 29 LEU C 572 ARG C 576 5 5 HELIX 30 30 ALA D 173 GLY D 178 1 6 HELIX 31 31 GLU D 180 LEU D 187 1 8 HELIX 32 32 PRO D 220 THR D 224 5 5 HELIX 33 33 MET D 243 ASN D 268 1 26 HELIX 34 34 ASP D 272 ASP D 295 1 24 HELIX 35 35 ASP D 295 GLY D 302 1 8 HELIX 36 36 GLY D 302 LEU D 310 1 9 HELIX 37 37 VAL D 327 PHE D 332 1 6 HELIX 38 38 ARG D 333 ILE D 339 5 7 HELIX 39 39 SER D 362 VAL D 364 5 3 HELIX 40 40 ALA D 367 GLU D 374 1 8 HELIX 41 41 ILE D 377 ALA D 386 1 10 HELIX 42 42 VAL D 399 GLU D 404 1 6 HELIX 43 43 ASP D 416 HIS D 428 1 13 HELIX 44 44 GLY D 432 CYS D 440 1 9 HELIX 45 45 THR D 447 ARG D 456 1 10 HELIX 46 46 ASN D 457 GLY D 469 1 13 HELIX 47 47 THR D 470 ILE D 474 5 5 HELIX 48 48 ASP D 475 GLU D 483 1 9 HELIX 49 49 GLY D 492 GLY D 509 1 18 HELIX 50 50 SER D 521 ALA D 529 1 9 HELIX 51 51 SER D 532 THR D 541 1 10 HELIX 52 52 SER D 565 LEU D 567 5 3 HELIX 53 53 LEU D 572 ARG D 576 5 5 SHEET 1 AA 2 ARG A 27 ALA A 28 0 SHEET 2 AA 2 ILE C 164 ASN C 165 -1 O ASN C 165 N ARG A 27 SHEET 1 AB 2 PRO A 78 SER A 83 0 SHEET 2 AB 2 PRO C 388 LYS C 390 -1 O ALA C 389 N ASP A 79 SHEET 1 BA 2 ARG B 27 ALA B 28 0 SHEET 2 BA 2 ILE D 164 ASN D 165 -1 N ASN D 165 O ARG B 27 SHEET 1 BB 2 PRO B 78 SER B 83 0 SHEET 2 BB 2 PRO D 388 LYS D 390 -1 O ALA D 389 N ASP B 79 SHEET 1 CA 2 LEU C 128 LYS C 129 0 SHEET 2 CA 2 CYS C 143 ILE C 144 -1 O ILE C 144 N LEU C 128 SHEET 1 CB 2 PHE C 342 PHE C 344 0 SHEET 2 CB 2 ARG C 358 PRO C 360 -1 O VAL C 359 N MET C 343 SHEET 1 CC 2 THR C 545 SER C 547 0 SHEET 2 CC 2 PHE C 561 ASN C 563 -1 O VAL C 562 N VAL C 546 SHEET 1 DA 2 PHE D 342 PHE D 344 0 SHEET 2 DA 2 ARG D 358 PRO D 360 -1 O VAL D 359 N MET D 343 SHEET 1 DB 2 THR D 545 SER D 547 0 SHEET 2 DB 2 PHE D 561 ASN D 563 -1 O VAL D 562 N VAL D 546 SSBOND 1 CYS A 1 CYS A 14 1555 1555 2.04 SSBOND 2 CYS B 1 CYS B 14 1555 1555 2.04 SSBOND 3 CYS C 115 CYS C 125 1555 1555 2.03 SSBOND 4 CYS C 119 CYS C 143 1555 1555 2.04 SSBOND 5 CYS C 153 CYS D 153 1555 1555 2.03 SSBOND 6 CYS C 221 CYS C 232 1555 1555 2.03 SSBOND 7 CYS C 440 CYS C 497 1555 1555 2.03 SSBOND 8 CYS C 538 CYS C 564 1555 1555 2.03 SSBOND 9 CYS D 115 CYS D 125 1555 1555 2.03 SSBOND 10 CYS D 119 CYS D 143 1555 1555 2.03 SSBOND 11 CYS D 221 CYS D 232 1555 1555 2.03 SSBOND 12 CYS D 440 CYS D 497 1555 1555 2.05 SSBOND 13 CYS D 538 CYS D 564 1555 1555 2.03 LINK OD2 ASP A 94 CMD HEM A 605 1555 1555 1.36 LINK CMB HEM A 605 OE2 GLU C 242 1555 1555 1.40 LINK CBB HEM A 605 SD MET C 243 1555 1555 1.63 LINK OD2 ASP B 94 CMD HEM B 605 1555 1555 1.35 LINK CMA HEM B 605 S12 PVW B 606 1555 1555 2.04 LINK CMB HEM B 605 OE2 GLU D 242 1555 1555 1.41 LINK CBB HEM B 605 SD MET D 243 1555 1555 1.61 LINK C SER C 149 N CSO C 150 1555 1555 1.33 LINK C CSO C 150 N PRO C 151 1555 1555 1.34 LINK ND2 ASN C 189 C1 NAG C1620 1555 1555 1.45 LINK ND2 ASN C 225 C1 NAG C1630 1555 1555 1.44 LINK ND2 ASN C 317 C1 NAG E 1 1555 1555 1.44 LINK C SER D 149 N CSO D 150 1555 1555 1.33 LINK C CSO D 150 N PRO D 151 1555 1555 1.35 LINK ND2 ASN D 189 C1 NAG D2620 1555 1555 1.45 LINK ND2 ASN D 225 C1 NAG D2630 1555 1555 1.44 LINK ND2 ASN D 317 C1 NAG F 1 1555 1555 1.44 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.44 LINK O6 NAG E 1 C1 FUC E 4 1555 1555 1.44 LINK O4 NAG E 2 C1 BMA E 3 1555 1555 1.45 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.44 LINK O4 NAG F 2 C1 BMA F 3 1555 1555 1.44 LINK O ASP A 96 CA CA C1580 1555 1555 2.30 LINK OD1 ASP A 96 CA CA C1580 1555 1555 2.47 LINK FE HEM A 605 NE2 HIS C 336 1555 1555 2.30 LINK O ASP B 96 CA CA D1580 1555 1555 2.20 LINK OD1 ASP B 96 CA CA D1580 1555 1555 2.50 LINK FE HEM B 605 NE2 HIS D 336 1555 1555 2.30 LINK O THR C 168 CA CA C1580 1555 1555 2.54 LINK OG1 THR C 168 CA CA C1580 1555 1555 2.36 LINK O PHE C 170 CA CA C1580 1555 1555 2.26 LINK OD1 ASP C 172 CA CA C1580 1555 1555 2.38 LINK OG SER C 174 CA CA C1580 1555 1555 2.44 LINK OG1 THR D 168 CA CA D1580 1555 1555 2.59 LINK O THR D 168 CA CA D1580 1555 1555 2.47 LINK O PHE D 170 CA CA D1580 1555 1555 2.35 LINK OD1 ASP D 172 CA CA D1580 1555 1555 2.48 LINK OG SER D 174 CA CA D1580 1555 1555 2.57 CISPEP 1 PRO C 123 PRO C 124 0 2.90 CISPEP 2 GLU C 354 PRO C 355 0 6.58 CISPEP 3 ASN C 549 ASN C 550 0 4.55 CISPEP 4 TYR C 557 PRO C 558 0 3.26 CISPEP 5 PRO D 123 PRO D 124 0 6.99 CISPEP 6 GLU D 354 PRO D 355 0 9.45 CISPEP 7 ASN D 549 ASN D 550 0 6.00 CISPEP 8 TYR D 557 PRO D 558 0 2.93 CRYST1 93.130 63.790 111.350 90.00 97.32 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010738 0.000000 0.001379 0.00000 SCALE2 0.000000 0.015676 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009054 0.00000